Recombinant erythropoietin biosimilar (Recpharma)
重组人促红素生物类似药 (Recpharma)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant erythropoietin biosimilar (Recpharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2015/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesReceptopharm
China Registration ClassN/A
Develop Information
Active CompaniesReceptopharm
Inactive CompaniesHannover Medical School
Active Indications
Inactive Indications
Other Information
ATC Code
Related LinksN/A